BRQ-14251-46095
4 vaccinations
4 coded responses
27 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 197 / DE
- Registered
- 2021-04-17
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-27
Dose 1 — Pfizer-BioNTech
-
2021-04-17
Registered in v-safe
-
2021-04-17
Dose 2 — Pfizer-BioNTech
- 2021-04-17
-
2021-04-18
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Underarm pain and soreness on the injection sideMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain, Oedema peripheral — Feeling: Fair · Site: Pain · Fatigue or tiredness, Abdominal painFree text: Underarm swelling and pain ( mild )MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: Fair · Site: PainFree text: Underarm soreness and painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-23
- 2021-04-24
- 2021-05-03
- 2021-05-10
-
2021-05-15
Survey response — day 28, dose 2MedDRA: Menstruation irregular — Feeling: FairFree text: Early periodsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-29
-
2021-11-04
Dose 3 — Pfizer-BioNTech
-
2021-11-04
Health check-in — day 0, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-11-07
-
2021-11-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-09
- 2022-02-03
- 2022-05-05
-
2022-10-21
Dose 4 — Pfizer-BioNTech
-
2022-10-22
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-23
- 2022-10-26
- 2022-10-27
- 2022-10-29
- 2022-11-06
- 2022-11-20
- 2022-11-25
- 2022-12-04
- 2023-01-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Pfizer-BioNTech | |
| 2 | 2021-04-17 | Pfizer-BioNTech | |
| 3 | 2021-11-04 | Pfizer-BioNTech | No |
| 4 | 2022-10-21 | Pfizer-BioNTech | No |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Underarm pain and soreness on the injection side
Systemic reaction (other): Underarm swelling and pain ( mild )
Systemic reaction (other): Underarm soreness and pain
Release 8 — day 28, dose 2
Symptoms: Early periods
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Menstruation irregular | ✓ | ✓ | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Oedema peripheral | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release